Related Experiment Video
Updated: Feb 2, 2026

Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes
Published on: July 4, 2007
Novel presentations of periodic fever syndromes: Discrepancies between genetic and clinical diagnoses
Tiffany K Hoang1, Daniel A Albert1
1Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, New Hampshire, USA.
Objective:
The Periodic fever syndromes (PFS) are a group of disorders of the innate immune system. We investigated patients diagnosed with PFS at the Dartmouth Hitchcock Pediatric Rheumatology Clinic.
Methods:
Case acquisition was performed by reviewing ICD 9/10 coded records for familial Mediterranean fever (ICD 9 277.31), laboratory test records for PFS genetic screening, and clinic records between 1/1/2011 and 12/31/2017.
Results:
Twenty-seven cases had clinical evaluations including PFS genetic screening. Clinical diagnoses included familial Mediterranean fever (FMF) (10 cases), Muckle-Wells (2 cases), tumor necrosis factor receptor associated periodic syndrome (TRAPS) (4 cases), hyper IgD syndrome (HIDS) (1 case), Crohn's Disease (1 case), systemic onset juvenile idiopathic arthritis (SoJIA) (1 case), fever of unknown origin (FUO) (1 case), periodic fever adenitis pharyngitis aphthous ulcer (PFAPA) (6 cases), and cold-induced urticaria (1 case). Fifteen cases were associated with a genetic cause. Seven of the 10 FMF cases were confirmed genetically and were either heterozygous or compound heterozygotes. Both cases of Muckle-Wells had either a compound heterozygote for CIAS 1 or a NOD gene mutation. Both TRAPS cases presented atypically with patients developing systemic lupus erythematosus (SLE) or being asymptomatic. Two patients had novel syndromes. One FMF patient had a TRNT1 gene mutation who responded to intravenous immunoglobulin (IVIg) and colchicine after failing multiple treatments. The other had SoJIA with a LPIN 2 gene mutation but responded to colchicine. Only one of the 15 genetically proven cases had classical presentation and genetics (HIDS secondary to a mevalonate kinase (MVK) gene mutation).
Conclusion:
PFS screening was helpful in over half of the cases to develop therapeutic treatment plans. Given the atypical clinical presentations seen with genetically determined PFS, extensive genetic testing is indicated for all patients presenting with a PFS, excluding classical PFAPA syndrome.
Insights
Periodic fever syndromes (PFS) often present atypically. Genetic screening aids in diagnosing these rare immune disorders and guides treatment plans for patients, even with novel mutations.
Area of Science:
- Rheumatology
- Immunology
- Genetics
Background:
- Periodic fever syndromes (PFS) are a group of innate immune system disorders.
- Accurate diagnosis and management of PFS are crucial for patient outcomes.
Purpose of the Study:
- To investigate patients diagnosed with PFS at a pediatric rheumatology clinic.
- To evaluate the utility of genetic screening in diagnosing and managing PFS.
Main Methods:
- Retrospective review of clinic and laboratory records from 2011-2017.
- Acquisition of cases using ICD codes for familial Mediterranean fever and PFS genetic screening records.
Main Results:
- Twenty-seven patients underwent clinical evaluation and PFS genetic screening.
- Diagnoses included familial Mediterranean fever, Muckle-Wells, TRAPS, HIDS, PFAPA, and others; 15 cases had a genetic cause.
- Atypical presentations were common, with novel syndromes identified; genetic testing guided treatment in over half of cases.
Conclusions:
- PFS genetic screening is valuable for developing therapeutic treatment plans.
- Extensive genetic testing is recommended for patients presenting with PFS due to atypical clinical presentations.
- Classical PFAPA syndrome is an exclusion for extensive genetic testing.
More Related Videos
09:13Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
07:25Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
Published on: October 13, 2023
Related Concept Videos
Self-Discrepancy Theory
Self-Presentation
Self-Discrepancy and Its Effects
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Self-Presentation: Self-Monitoring and Self-Handicapping
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are: